
time-chf,<https://w3id.org/CMEO/time-chf/randomized_controlled_trial/protocol>,<https://w3id.org/CMEO/time-chf/comparator>,standard guided therapy,comparative study with an intensified treatment strategy guided by nt-bnp levels against standard symptom-guided therapy in chronic heart failure patients patients aged 60-74 years and those 75 years or older,<= 84.5 and >= 69.3 years old,age distribution,,
viennadiabetes,<https://w3id.org/CMEO/believe/observational_design/protocol>,<https://w3id.org/CMEO/viennadiabetes/eligibility_criterion>,"cohort study - no specific intervention, routine clinical care","the study is designed  to quantify the burden and trends of non-communicable diseases (ncds), including cardiovascular, metabolic, respiratory, and neoplastic diseases, and related risk factors across different geographical settings in bangladesh and identify their demographic, societal, economic, and hereditary drivers.",> 11 years old,angina,,
viennahf-register,<https://w3id.org/CMEO/believe/observational_design/protocol>,<https://w3id.org/CMEO/viennahf-register/eligibility_criterion>,1085,"the study is designed  to quantify the burden and trends of non-communicable diseases (ncds), including cardiovascular, metabolic, respiratory, and neoplastic diseases, and related risk factors across different geographical settings in bangladesh and identify their demographic, societal, economic, and hereditary drivers.",> 11 years old,angina,,
gissi-hf-outcomes,<https://w3id.org/CMEO/gissi-hf-outcomes/randomized_controlled_trial/protocol>,<https://w3id.org/CMEO/gissi-hf-outcomes/comparator>,Placebo,to investigate whether long-term administration of n-3 pufa and rosuvastatin is more effective than the corresponding placebo in reducing all-cause mortality and all-cause mortality or hospitalizations for cardiovascular reasons,>= 18 years old,age distribution,,
gissi-hf,<https://w3id.org/CMEO/gissi-hf/randomized_controlled_trial/protocol>,<https://w3id.org/CMEO/gissi-hf/comparator>,Placebo,to investigate whether long-term administration of n-3 pufa and rosuvastatin is more effective than the corresponding placebo in reducing all-cause mortality and all-cause mortality or hospitalizations for cardiovascular reasons,<= 78 and >= 56 years old,age distribution,,
ucd-hf-cohort,<https://w3id.org/CMEO/ucd-hf-cohort/observational_design/protocol>,<https://w3id.org/CMEO/ucd-hf-cohort/eligibility_criterion>,25,"the study is designed  to quantify the burden and trends of non-communicable diseases (ncds), including cardiovascular, metabolic, respiratory, and neoplastic diseases, and related risk factors across different geographical settings in bangladesh and identify their demographic, societal, economic, and hereditary drivers.",> 11 years old,angina,,
avanti,<https://w3id.org/CMEO/avanti/randomized_controlled_trial/protocol>,<https://w3id.org/CMEO/avanti/eligibility_criterion>,571,"the study is designed  to quantify the burden and trends of non-communicable diseases (ncds), including cardiovascular, metabolic, respiratory, and neoplastic diseases, and related risk factors across different geographical settings in bangladesh and identify their demographic, societal, economic, and hereditary drivers.",> 11 years old,angina,,
cachexia,<https://w3id.org/CMEO/cachexia/observational_design/protocol>,<https://w3id.org/CMEO/cachexia/eligibility_criterion>,200,"the study is designed  to quantify the burden and trends of non-communicable diseases (ncds), including cardiovascular, metabolic, respiratory, and neoplastic diseases, and related risk factors across different geographical settings in bangladesh and identify their demographic, societal, economic, and hereditary drivers.",> 11 years old,angina,,
aachenhf,<https://w3id.org/CMEO/aachenhf/observational_design/protocol>,<https://w3id.org/CMEO/aachenhf/eligibility_criterion>,250,"the study is designed  to quantify the burden and trends of non-communicable diseases (ncds), including cardiovascular, metabolic, respiratory, and neoplastic diseases, and related risk factors across different geographical settings in bangladesh and identify their demographic, societal, economic, and hereditary drivers.",<= 77.5 and >= 51.5 years old,age distribution,,
